Page 312 - ATP-P 11th Ed
P. 312

•   Vertigo
        •   Palpitations
        •   Dry mouth
        •   Constipation
        •   Dysuria
        •   Urine retention
        TMEP use:
        •   Allergic Rhinitis/Hay Fever/Cold Like Symptoms Protocol
        •   Anaphylactic Reaction Protocol
        •   Contact Dermatitis Protocol
        •   Envenomation Protocol
        •  K9 Anaphylactic Reactions and Envenomation Protocol
        •   Nausea and Vomiting Protocol
               ®
        Dulcolax  – See Bisacodyl
   SECTION 3  Efavirenz and Emtricitabine and Tenofovir – See Atripla
                                                 ®
        Emtricitabine and Efavirenz and Tenofovir – See Atripla
                                                 ®
        Emtricitabine and Tenofovir – See Truvada ®

                          ®
        Epinephrine (Adrenaline )
              GROUNDING medication for personnel on flight status
        Description: Alpha and beta adrenergic sympathomimetic
        •   First-line drug for anaphylaxis (See ACLS drugs for cardiac therapy)
        •   Causes bronchodilatation, vasoconstriction, increases blood pressure
        •   Decreases edema/swelling due to allergic reactions
          Note:
          °   1:1,000 dilution epinephrine (1mg in 1mL) is standard pararescue issue.
          °    1:10,000 dilution (1mg in 10mL) is the standard ‘Cardiac’ dosage form for IV use.
          °    1:1,000 epinephrine can be diluted to the 1:10,000 form by putting 1mL of 1:1,000
            epinephrine (1mg epinephrine) in 9mL of normal saline (total volume of 10mL).
        Indications: Anaphylaxis
        •   Allergic reactions (mild/moderate/severe)
        •   Asthma
        Adult dose (Epinephrine):
        •   Anaphylaxis: 0.3–0.5mg (3–5mL of 1:10,000 dilution) IV or 0.3–0.5mg (0.3–0.5mL of
          1:1,000 dilution) IM
        •   Allergic reaction: 0.3–0.5mg (0.3–0.5mL of 1:1,000 dilution) SQ/IM
        •   Asthma: 0.3–0.5mg (0.3–0.5mL of 1:1,000 dilution) SQ/IM

          302  SECTION 3   RECOMMENDED DRUG LIST (RDL)
   307   308   309   310   311   312   313   314   315   316   317